Indiziert in
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Akademische Schlüssel
  • JournalTOCs
  • Forschungsbibel
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Scimago
  • Ulrichs Zeitschriftenverzeichnis
  • Elektronische Zeitschriftenbibliothek
  • RefSeek
  • Hamdard-Universität
  • EBSCO AZ
  • OCLC – WorldCat
  • SWB Online-Katalog
  • Virtuelle Bibliothek für Biologie (vifabio)
  • Publons
  • MIAR
  • Wissenschaftliche Indexierungsdienste (SIS)
  • Euro-Pub
  • Google Scholar
Teile diese Seite
Zeitschriftenflyer
Flyer image

Abstrakt

Nanobiopharmaceutics: Advancing Medicine through Nanotechnology and Biopharmaceuticals

Dr. Saad Slaiki*

Nanobiopharmaceutics is an interdisciplinary field that combines the principles of nanotechnology and biopharmaceutics to develop novel drug delivery systems for improved therapeutic outcomes. This emerging field aims to overcome the limitations of conventional pharmaceutical formulations by utilizing nanoscale materials and techniques to enhance drug stability, bioavailability, targeting, and controlled release. Nanobiopharmaceutics encompasses a wide range of approaches, including the design and synthesis of nanocarriers, nanoscale drug delivery systems, nanodiagnostics, and nanotherapeutics. This abstract provides an overview of the key concepts, applications, and challenges in the field of nanobiopharmaceutics, highlighting its potential to revolutionize the field of medicine and improve patient care.

Nanobiopharmaceutics is an emerging field at the intersection of nanotechnology, biotechnology, and pharmaceutical sciences, which explores the utilization of nanomaterials and nanoscale devices for drug delivery and therapeutic applications. By harnessing the unique properties and functionalities of nanosystems, nanobiopharmaceutics aims to overcome the limitations of conventional drug formulations and improve the efficacy, safety, and targeting of pharmaceutical agents. This abstract provides an overview of the principles, applications, and challenges associated with nanobiopharmaceutics, highlighting its potential to revolutionize the field of medicine.

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert.